These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29624646)

  • 21. Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia?
    Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baleanu BC; Paunica S
    Exp Dermatol; 2016 Jul; 25(7):557-8. PubMed ID: 26990657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.
    Chiriacò G; Cauci S; Mazzon G; Trombetta C
    Andrology; 2016 Mar; 4(2):245-50. PubMed ID: 26763726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Said MA; Mehta A
    Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible myopathy and ophthalmoparesis after low-dose finasteride administration for androgenic alopecia.
    Ryu HJ; Kwon DY
    Dermatol Surg; 2014 May; 40(5):595-7. PubMed ID: 24533595
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
    Melcangi RC; Caruso D; Abbiati F; Giatti S; Calabrese D; Piazza F; Cavaletti G
    J Sex Med; 2013 Oct; 10(10):2598-603. PubMed ID: 23890183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A serious side effect of a potentially widely used cosmetic product.
    Smith VM; Cockshoot D
    Clin Exp Dermatol; 2015 Apr; 40(3):347-8. PubMed ID: 25622515
    [No Abstract]   [Full Text] [Related]  

  • 27. Post-finasteride syndrome: a surmountable challenge for clinicians.
    Traish AM
    Fertil Steril; 2020 Jan; 113(1):21-50. PubMed ID: 32033719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
    Lynn R; Krunic A
    Dermatol Ther; 2010; 23(5):544-6. PubMed ID: 20868409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss.
    Yeon JH; Jung JY; Choi JW; Kim BJ; Youn SW; Park KC; Huh CH
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):211-4. PubMed ID: 20569283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finasteride and androgenic alopecia; from therapeutic options to medical implications.
    Motofei IG; Rowland DL; Tampa M; Sarbu MI; Mitran MI; Mitran CI; Stoian AP; Diaconu CC; Paunica S; Georgescu SR
    J Dermatolog Treat; 2020 Jun; 31(4):415-421. PubMed ID: 30897009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain.
    Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baconi D; Stefanescu E; Baleanu BC; Balalau C; Constantin V; Paunica S
    J Dermatolog Treat; 2016 Nov; 27(6):495-497. PubMed ID: 27046152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and use of finasteride in women: a systematic review.
    Hu AC; Chapman LW; Mesinkovska NA
    Int J Dermatol; 2019 Jul; 58(7):759-776. PubMed ID: 30604525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finasteride-associated male infertility.
    Chiba K; Yamaguchi K; Li F; Ando M; Fujisawa M
    Fertil Steril; 2011 Apr; 95(5):1786.e9-11. PubMed ID: 21193189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate, baldness drugs linked to sexual dysfunction.
    Kuehn BM
    JAMA; 2012 May; 307(18):1903. PubMed ID: 22570451
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
    Wu M; Yu Q; Li Q
    Oncotarget; 2016 Dec; 7(50):82074-82084. PubMed ID: 27738338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain.
    Motofei IG; Rowland DL; Manea M; Georgescu SR; Păunică I; Sinescu I
    Clin Drug Investig; 2017 Jun; 37(6):511-517. PubMed ID: 28161756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
    Ganzer CA; Jacobs AR; Iqbal F
    Am J Mens Health; 2015 May; 9(3):222-8. PubMed ID: 24928450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical post-finasteride syndrome: A pharmacological riddle.
    Gupta AK; Sharma N; Shukla P
    Indian J Pharmacol; 2016; 48(3):316-7. PubMed ID: 27298504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan].
    Tsuji Y; Nakayama T; Bono K; Kitamura M; Imafuku I
    Rinsho Shinkeigaku; 2014; 54(5):423-8. PubMed ID: 24943080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.